Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calendar
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Tri-Conference
    • Next Generation Dx
    • Dx Innovation Summit
  • About
    • Editorial Profile
    • Editorial Calendar
    • Contact
  • Next Generation Dx Summit
 
  • All of Us Announces First Return of Health-Related DNA Results

    Diagnostics World News | The National Institutes of Health's All of Us Research Program has begun returning personalized health-related DNA results to more than 155,000 participants, with reports detailing whether participants have an increased risk for specific health conditions and how their body might process certain medications.

    Dec 13, 2022
  • Exosome-Based CDx Tests Could Bring Precision Medicine to Neurodegenerative Diseases

    Diagnostics World News | Liquid biopsies based on circulating tumor DNA or tumor cells have remarkably improved our prognostic and diagnostic capabilities in oncology. Now, exosome-based liquid biopsies bring the benefits of non-biopsy approaches to a broader range of medical areas.

    Dec 9, 2022
  • Mapping the Vagus Nerve: Researchers Look to Pave the Way for Bioelectronic Breakthroughs

    Diagnostics World News | Researchers have their sights set on creating a first-of-its-kind anatomical map of the vagus nerve. Stavros Zanos of the Feinstein Institutes for Medical Research is leading a three-year-long research study called Reconstructing Vagal Anatomy. The NIH-supported project plans to share the map with the greater scientific community in hopes of leading to new breakthroughs in the field of bioelectronic medicine.

    Dec 8, 2022
  • Tumor Fraction Shows Promise as Tumor-Agnostic Prognostic Tool

    Diagnostics World News | A research team from The Ohio State University and Foundation Medicine suggests that tumor fraction has the potential to serve as a pragmatic, tumor-agnostic prognostic tool. They published their results in Annals of Oncology last month.

    Dec 6, 2022
  • Saliva-Based Test to Diagnose Concussions, Blood Test Detects Cancer Two Years Before Formal Diagnosis, More

    Diagnostics World News | A deep learning model that uses a single chest X-ray to predict the 10-year risk of death from a heart attack or stroke; a new blood test to improve early detection and diagnosis of clinically significant prostate cancer in patients by minimizing unnecessary invasive tissue biopsies; real-time PCR technology to screen for spinal muscular atrophy and severe combined immunodeficiency using a single dried blood spot sample; and more.

    Nov 30, 2022
  • Follow the Money: Ultrasensitive ctDNA Personalized Cancer Diagnostic Test, Advanced Brain Cancer Diagnostics, More

    Diagnostics World News | Funding for chronic kidney disease and acute kidney injury genetic testing, minimal residual disease testing for solid tumors, and more.

    Nov 29, 2022
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70 (current)
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Twitter Icon LinkedIn Icon Facebook Icon

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy